avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxp2
|
ENSMUSG00000029563.10 | forkhead box P2 |
Foxp3
|
ENSMUSG00000039521.6 | forkhead box P3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxp3 | mm10_v2_chrX_+_7580483_7580491 | -0.64 | 2.4e-05 | Click! |
Foxp2 | mm10_v2_chr6_+_15185439_15185452 | 0.23 | 1.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_81975742 | 6.03 |
ENSMUST00000029645.8
|
Tdo2
|
tryptophan 2,3-dioxygenase |
chr9_+_53301571 | 2.99 |
ENSMUST00000051014.1
|
Exph5
|
exophilin 5 |
chr1_-_130661584 | 2.95 |
ENSMUST00000137276.2
|
C4bp
|
complement component 4 binding protein |
chr1_-_139781236 | 2.93 |
ENSMUST00000027612.8
ENSMUST00000111989.2 ENSMUST00000111986.2 |
Gm4788
|
predicted gene 4788 |
chr1_-_162898665 | 2.90 |
ENSMUST00000111510.1
ENSMUST00000045902.6 |
Fmo2
|
flavin containing monooxygenase 2 |
chr1_-_162898484 | 2.79 |
ENSMUST00000143123.1
|
Fmo2
|
flavin containing monooxygenase 2 |
chr1_-_130661613 | 2.77 |
ENSMUST00000027657.7
|
C4bp
|
complement component 4 binding protein |
chr17_+_36942910 | 2.44 |
ENSMUST00000040498.5
|
Rnf39
|
ring finger protein 39 |
chr14_-_51913393 | 2.28 |
ENSMUST00000004673.7
ENSMUST00000111632.3 |
Ndrg2
|
N-myc downstream regulated gene 2 |
chr4_-_19922599 | 2.22 |
ENSMUST00000029900.5
|
Atp6v0d2
|
ATPase, H+ transporting, lysosomal V0 subunit D2 |
chr10_+_93488766 | 2.20 |
ENSMUST00000129421.1
|
Hal
|
histidine ammonia lyase |
chr15_-_78468620 | 2.18 |
ENSMUST00000017086.3
|
Tmprss6
|
transmembrane serine protease 6 |
chr10_+_127898515 | 2.15 |
ENSMUST00000047134.7
|
Sdr9c7
|
4short chain dehydrogenase/reductase family 9C, member 7 |
chr6_+_121346618 | 2.13 |
ENSMUST00000032200.9
|
Slc6a12
|
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
chr11_+_70214105 | 2.12 |
ENSMUST00000094055.3
ENSMUST00000136328.1 ENSMUST00000126296.1 ENSMUST00000153993.2 |
Slc16a11
|
solute carrier family 16 (monocarboxylic acid transporters), member 11 |
chr17_+_36943025 | 2.11 |
ENSMUST00000173072.1
|
Rnf39
|
ring finger protein 39 |
chr3_+_107230608 | 2.08 |
ENSMUST00000179399.1
|
A630076J17Rik
|
RIKEN cDNA A630076J17 gene |
chr14_+_55560904 | 2.03 |
ENSMUST00000072530.4
ENSMUST00000128490.1 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr11_+_70213910 | 2.00 |
ENSMUST00000171032.1
|
Slc16a11
|
solute carrier family 16 (monocarboxylic acid transporters), member 11 |
chr11_-_84167466 | 1.94 |
ENSMUST00000050771.7
|
Gm11437
|
predicted gene 11437 |
chr12_-_103904887 | 1.91 |
ENSMUST00000074051.5
|
Serpina1c
|
serine (or cysteine) peptidase inhibitor, clade A, member 1C |
chr12_-_103773592 | 1.91 |
ENSMUST00000078869.5
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chr5_+_90561102 | 1.79 |
ENSMUST00000094615.4
|
5830473C10Rik
|
RIKEN cDNA 5830473C10 gene |
chr14_+_55560480 | 1.78 |
ENSMUST00000121622.1
ENSMUST00000143431.1 ENSMUST00000150481.1 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr14_+_55561060 | 1.75 |
ENSMUST00000117701.1
|
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr11_+_70054334 | 1.74 |
ENSMUST00000018699.6
ENSMUST00000108585.2 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr8_-_121944886 | 1.71 |
ENSMUST00000057653.7
|
Car5a
|
carbonic anhydrase 5a, mitochondrial |
chr15_+_25940846 | 1.69 |
ENSMUST00000110438.1
|
Fam134b
|
family with sequence similarity 134, member B |
chr19_+_23141183 | 1.69 |
ENSMUST00000036884.1
|
Klf9
|
Kruppel-like factor 9 |
chr2_+_58755177 | 1.61 |
ENSMUST00000102755.3
|
Upp2
|
uridine phosphorylase 2 |
chr7_+_140763739 | 1.60 |
ENSMUST00000026552.7
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr8_-_36953139 | 1.60 |
ENSMUST00000179501.1
|
Dlc1
|
deleted in liver cancer 1 |
chr2_-_148040196 | 1.58 |
ENSMUST00000136555.1
|
9030622O22Rik
|
RIKEN cDNA 9030622O22 gene |
chr18_-_38918642 | 1.57 |
ENSMUST00000040647.4
|
Fgf1
|
fibroblast growth factor 1 |
chr19_+_30232921 | 1.53 |
ENSMUST00000025797.5
|
Mbl2
|
mannose-binding lectin (protein C) 2 |
chr8_-_84773381 | 1.52 |
ENSMUST00000109764.1
|
Nfix
|
nuclear factor I/X |
chr1_+_130865669 | 1.50 |
ENSMUST00000038829.5
|
Faim3
|
Fas apoptotic inhibitory molecule 3 |
chr12_-_103657159 | 1.48 |
ENSMUST00000044159.6
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr2_+_58754910 | 1.47 |
ENSMUST00000059102.6
|
Upp2
|
uridine phosphorylase 2 |
chr4_+_144893077 | 1.46 |
ENSMUST00000154208.1
|
Dhrs3
|
dehydrogenase/reductase (SDR family) member 3 |
chr2_+_68117713 | 1.46 |
ENSMUST00000112346.2
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr6_+_134830145 | 1.45 |
ENSMUST00000046303.5
|
Crebl2
|
cAMP responsive element binding protein-like 2 |
chr15_-_58214882 | 1.43 |
ENSMUST00000022986.6
|
Fbxo32
|
F-box protein 32 |
chrX_+_101376359 | 1.41 |
ENSMUST00000119080.1
|
Gjb1
|
gap junction protein, beta 1 |
chr15_+_99392882 | 1.40 |
ENSMUST00000023749.8
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr11_+_114851142 | 1.38 |
ENSMUST00000133245.1
ENSMUST00000122967.2 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr9_-_45955170 | 1.38 |
ENSMUST00000162072.1
|
Sidt2
|
SID1 transmembrane family, member 2 |
chr12_-_103657095 | 1.36 |
ENSMUST00000152517.1
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr15_+_99392948 | 1.35 |
ENSMUST00000161250.1
ENSMUST00000160635.1 ENSMUST00000161778.1 |
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr4_+_104766334 | 1.35 |
ENSMUST00000065072.6
|
C8b
|
complement component 8, beta polypeptide |
chr15_+_99393219 | 1.33 |
ENSMUST00000159209.1
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr4_+_144893127 | 1.32 |
ENSMUST00000142808.1
|
Dhrs3
|
dehydrogenase/reductase (SDR family) member 3 |
chr11_+_70092634 | 1.31 |
ENSMUST00000102572.1
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr5_-_87569023 | 1.30 |
ENSMUST00000113314.2
|
Sult1d1
|
sulfotransferase family 1D, member 1 |
chr10_+_87859593 | 1.30 |
ENSMUST00000126490.1
|
Igf1
|
insulin-like growth factor 1 |
chr11_+_70092705 | 1.29 |
ENSMUST00000124721.1
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr12_-_103863551 | 1.29 |
ENSMUST00000085056.6
ENSMUST00000072876.5 ENSMUST00000124717.1 |
Serpina1a
|
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
chr2_-_134554348 | 1.28 |
ENSMUST00000028704.2
|
Hao1
|
hydroxyacid oxidase 1, liver |
chr6_-_138079916 | 1.27 |
ENSMUST00000171804.1
|
Slc15a5
|
solute carrier family 15, member 5 |
chr2_+_28641227 | 1.27 |
ENSMUST00000028155.5
ENSMUST00000113869.1 ENSMUST00000113867.2 |
Tsc1
|
tuberous sclerosis 1 |
chr4_+_144892813 | 1.26 |
ENSMUST00000105744.1
ENSMUST00000171001.1 |
Dhrs3
|
dehydrogenase/reductase (SDR family) member 3 |
chr11_+_70092653 | 1.26 |
ENSMUST00000143772.1
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr9_+_46268601 | 1.23 |
ENSMUST00000121598.1
|
Apoa5
|
apolipoprotein A-V |
chr4_+_104766308 | 1.22 |
ENSMUST00000031663.3
|
C8b
|
complement component 8, beta polypeptide |
chrX_-_139782353 | 1.22 |
ENSMUST00000101217.3
|
Ripply1
|
ripply1 homolog (zebrafish) |
chr2_+_4718145 | 1.21 |
ENSMUST00000056914.6
|
Bend7
|
BEN domain containing 7 |
chr11_+_78499087 | 1.20 |
ENSMUST00000017488.4
|
Vtn
|
vitronectin |
chr7_-_133782721 | 1.20 |
ENSMUST00000063669.1
|
Dhx32
|
DEAH (Asp-Glu-Ala-His) box polypeptide 32 |
chr6_-_124911636 | 1.19 |
ENSMUST00000032217.1
|
Lag3
|
lymphocyte-activation gene 3 |
chr13_+_89540636 | 1.18 |
ENSMUST00000022108.7
|
Hapln1
|
hyaluronan and proteoglycan link protein 1 |
chr5_-_87254804 | 1.16 |
ENSMUST00000075858.3
|
Ugt2b37
|
UDP glucuronosyltransferase 2 family, polypeptide B37 |
chr15_-_5063741 | 1.16 |
ENSMUST00000110689.3
|
C7
|
complement component 7 |
chr12_-_84450944 | 1.15 |
ENSMUST00000085192.5
|
Aldh6a1
|
aldehyde dehydrogenase family 6, subfamily A1 |
chr4_+_133553370 | 1.12 |
ENSMUST00000042706.2
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr11_-_86993682 | 1.11 |
ENSMUST00000018571.4
|
Ypel2
|
yippee-like 2 (Drosophila) |
chr4_-_104876383 | 1.11 |
ENSMUST00000064873.8
ENSMUST00000106808.3 ENSMUST00000048947.8 |
C8a
|
complement component 8, alpha polypeptide |
chr15_-_3582596 | 1.09 |
ENSMUST00000161770.1
|
Ghr
|
growth hormone receptor |
chrX_-_7681034 | 1.08 |
ENSMUST00000115695.3
|
Magix
|
MAGI family member, X-linked |
chr4_+_45012830 | 1.08 |
ENSMUST00000095105.1
|
1700055D18Rik
|
RIKEN cDNA 1700055D18 gene |
chr6_+_134830216 | 1.07 |
ENSMUST00000111937.1
|
Crebl2
|
cAMP responsive element binding protein-like 2 |
chr11_+_97685903 | 1.07 |
ENSMUST00000107583.2
|
Cisd3
|
CDGSH iron sulfur domain 3 |
chr5_-_87091150 | 1.05 |
ENSMUST00000154455.1
|
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr14_-_55560340 | 1.05 |
ENSMUST00000066106.3
|
A730061H03Rik
|
RIKEN cDNA A730061H03 gene |
chrX_+_139800795 | 1.03 |
ENSMUST00000054889.3
|
Cldn2
|
claudin 2 |
chr9_-_45955226 | 1.03 |
ENSMUST00000038488.9
|
Sidt2
|
SID1 transmembrane family, member 2 |
chr19_-_58455903 | 1.02 |
ENSMUST00000131877.1
|
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr1_-_179546261 | 1.02 |
ENSMUST00000027769.5
|
Tfb2m
|
transcription factor B2, mitochondrial |
chr11_-_121388186 | 1.02 |
ENSMUST00000106107.2
|
Rab40b
|
Rab40b, member RAS oncogene family |
chr15_+_3270767 | 1.02 |
ENSMUST00000082424.4
ENSMUST00000159158.1 ENSMUST00000159216.1 ENSMUST00000160311.1 |
Sepp1
|
selenoprotein P, plasma, 1 |
chr7_+_113207465 | 0.98 |
ENSMUST00000047321.7
|
Arntl
|
aryl hydrocarbon receptor nuclear translocator-like |
chr6_+_79818031 | 0.98 |
ENSMUST00000179797.1
|
Gm20594
|
predicted gene, 20594 |
chr17_-_31144271 | 0.98 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr10_+_60106452 | 0.97 |
ENSMUST00000165024.2
|
Spock2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
chr17_+_12584183 | 0.97 |
ENSMUST00000046959.7
|
Slc22a2
|
solute carrier family 22 (organic cation transporter), member 2 |
chr15_-_3583146 | 0.96 |
ENSMUST00000110698.2
|
Ghr
|
growth hormone receptor |
chr3_+_5218516 | 0.96 |
ENSMUST00000175866.1
|
Zfhx4
|
zinc finger homeodomain 4 |
chr10_-_41579207 | 0.95 |
ENSMUST00000095227.3
|
Ccdc162
|
coiled-coil domain containing 162 |
chr3_+_146597077 | 0.94 |
ENSMUST00000029837.7
ENSMUST00000121133.1 |
Uox
|
urate oxidase |
chr3_+_52268337 | 0.92 |
ENSMUST00000053764.5
|
Foxo1
|
forkhead box O1 |
chr1_-_180195981 | 0.92 |
ENSMUST00000027766.6
ENSMUST00000161814.1 |
Adck3
|
aarF domain containing kinase 3 |
chr13_-_22219820 | 0.91 |
ENSMUST00000057516.1
|
Vmn1r193
|
vomeronasal 1 receptor 193 |
chr18_+_5593566 | 0.91 |
ENSMUST00000160910.1
|
Zeb1
|
zinc finger E-box binding homeobox 1 |
chr10_-_18234930 | 0.91 |
ENSMUST00000052648.8
ENSMUST00000080860.6 ENSMUST00000173243.1 |
Ccdc28a
|
coiled-coil domain containing 28A |
chr5_-_145879857 | 0.90 |
ENSMUST00000035918.7
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr19_-_58455161 | 0.89 |
ENSMUST00000135730.1
ENSMUST00000152507.1 |
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr5_+_90460889 | 0.87 |
ENSMUST00000031314.8
|
Alb
|
albumin |
chr15_-_5108469 | 0.86 |
ENSMUST00000141020.1
|
Card6
|
caspase recruitment domain family, member 6 |
chr19_-_8218832 | 0.86 |
ENSMUST00000113298.2
|
Slc22a29
|
solute carrier family 22. member 29 |
chr6_+_116650674 | 0.86 |
ENSMUST00000067354.5
ENSMUST00000178241.1 |
8430408G22Rik
|
RIKEN cDNA 8430408G22 gene |
chr12_-_83597140 | 0.85 |
ENSMUST00000048319.4
|
Zfyve1
|
zinc finger, FYVE domain containing 1 |
chr13_+_60602182 | 0.85 |
ENSMUST00000044083.7
|
Dapk1
|
death associated protein kinase 1 |
chr3_+_138217814 | 0.85 |
ENSMUST00000090171.5
|
Adh7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chrX_-_140543177 | 0.84 |
ENSMUST00000055738.5
|
Tsc22d3
|
TSC22 domain family, member 3 |
chr12_-_99393010 | 0.84 |
ENSMUST00000177451.1
|
Foxn3
|
forkhead box N3 |
chr2_-_58052832 | 0.84 |
ENSMUST00000090940.5
|
Ermn
|
ermin, ERM-like protein |
chr10_+_87860030 | 0.84 |
ENSMUST00000062862.6
|
Igf1
|
insulin-like growth factor 1 |
chr19_-_28963863 | 0.84 |
ENSMUST00000161813.1
|
4430402I18Rik
|
RIKEN cDNA 4430402I18 gene |
chr1_+_171225054 | 0.83 |
ENSMUST00000111321.1
ENSMUST00000005824.5 ENSMUST00000111320.1 ENSMUST00000111319.1 |
Apoa2
|
apolipoprotein A-II |
chr18_-_39489157 | 0.83 |
ENSMUST00000131885.1
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr3_+_94362444 | 0.83 |
ENSMUST00000169433.1
|
C2cd4d
|
C2 calcium-dependent domain containing 4D |
chr9_-_45954966 | 0.82 |
ENSMUST00000114573.2
|
Sidt2
|
SID1 transmembrane family, member 2 |
chr5_+_102481374 | 0.81 |
ENSMUST00000094559.2
ENSMUST00000073302.5 |
Arhgap24
|
Rho GTPase activating protein 24 |
chr12_-_57546121 | 0.81 |
ENSMUST00000044380.6
|
Foxa1
|
forkhead box A1 |
chr19_-_58455398 | 0.80 |
ENSMUST00000026076.7
|
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr14_-_31640878 | 0.80 |
ENSMUST00000167066.1
ENSMUST00000127204.2 ENSMUST00000022437.8 |
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr4_+_97777606 | 0.80 |
ENSMUST00000075448.6
ENSMUST00000092532.6 |
Nfia
|
nuclear factor I/A |
chr19_+_4855129 | 0.79 |
ENSMUST00000119694.1
|
Ctsf
|
cathepsin F |
chr8_+_45627946 | 0.79 |
ENSMUST00000145458.1
|
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr19_+_42090422 | 0.79 |
ENSMUST00000066778.4
|
Pi4k2a
|
phosphatidylinositol 4-kinase type 2 alpha |
chr15_+_59648644 | 0.79 |
ENSMUST00000118228.1
|
Trib1
|
tribbles homolog 1 (Drosophila) |
chr19_+_31868754 | 0.78 |
ENSMUST00000075838.5
|
A1cf
|
APOBEC1 complementation factor |
chr6_+_30541582 | 0.78 |
ENSMUST00000096066.4
|
Cpa2
|
carboxypeptidase A2, pancreatic |
chr15_+_59648350 | 0.78 |
ENSMUST00000067543.6
|
Trib1
|
tribbles homolog 1 (Drosophila) |
chr4_+_97772734 | 0.77 |
ENSMUST00000152023.1
|
Nfia
|
nuclear factor I/A |
chr19_-_34879452 | 0.76 |
ENSMUST00000036584.5
|
Pank1
|
pantothenate kinase 1 |
chr6_+_51432663 | 0.75 |
ENSMUST00000005103.5
|
Nfe2l3
|
nuclear factor, erythroid derived 2, like 3 |
chr5_-_45450121 | 0.75 |
ENSMUST00000127562.1
|
Qdpr
|
quinoid dihydropteridine reductase |
chr1_+_106171752 | 0.75 |
ENSMUST00000061047.6
|
Phlpp1
|
PH domain and leucine rich repeat protein phosphatase 1 |
chr9_+_47530173 | 0.74 |
ENSMUST00000114548.1
ENSMUST00000152459.1 ENSMUST00000143026.1 ENSMUST00000085909.2 ENSMUST00000114547.1 ENSMUST00000034581.3 |
Cadm1
|
cell adhesion molecule 1 |
chr14_+_33941021 | 0.73 |
ENSMUST00000100720.1
|
Gdf2
|
growth differentiation factor 2 |
chr3_+_90254163 | 0.73 |
ENSMUST00000029545.8
|
Crtc2
|
CREB regulated transcription coactivator 2 |
chr5_-_87424201 | 0.73 |
ENSMUST00000072818.5
|
Ugt2b38
|
UDP glucuronosyltransferase 2 family, polypeptide B38 |
chr18_-_39489880 | 0.72 |
ENSMUST00000152853.1
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr16_+_43235856 | 0.72 |
ENSMUST00000146708.1
|
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr5_-_77115145 | 0.71 |
ENSMUST00000081964.5
|
Hopx
|
HOP homeobox |
chr11_+_77765588 | 0.71 |
ENSMUST00000164315.1
|
Myo18a
|
myosin XVIIIA |
chr1_-_139560158 | 0.70 |
ENSMUST00000160423.1
ENSMUST00000023965.5 |
Cfhr1
|
complement factor H-related 1 |
chr5_+_102481546 | 0.70 |
ENSMUST00000112854.1
|
Arhgap24
|
Rho GTPase activating protein 24 |
chr13_-_52929458 | 0.70 |
ENSMUST00000123599.1
|
Auh
|
AU RNA binding protein/enoyl-coenzyme A hydratase |
chr15_-_5108492 | 0.70 |
ENSMUST00000118365.2
|
Card6
|
caspase recruitment domain family, member 6 |
chr17_-_34627365 | 0.70 |
ENSMUST00000064953.8
ENSMUST00000170345.1 ENSMUST00000171121.2 ENSMUST00000168391.2 ENSMUST00000169067.2 |
Ppt2
|
palmitoyl-protein thioesterase 2 |
chr6_+_124916863 | 0.70 |
ENSMUST00000069553.2
|
A230083G16Rik
|
RIKEN cDNA A230083G16 gene |
chr11_+_108395288 | 0.70 |
ENSMUST00000000049.5
|
Apoh
|
apolipoprotein H |
chr2_-_110305730 | 0.70 |
ENSMUST00000046233.2
|
Bbox1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase) |
chr2_+_176236860 | 0.69 |
ENSMUST00000166464.1
|
2210418O10Rik
|
RIKEN cDNA 2210418O10 gene |
chr11_+_119022962 | 0.69 |
ENSMUST00000026662.7
|
Cbx2
|
chromobox 2 |
chr6_-_136875794 | 0.69 |
ENSMUST00000032342.1
|
Mgp
|
matrix Gla protein |
chr4_-_45012093 | 0.68 |
ENSMUST00000131991.1
|
Zbtb5
|
zinc finger and BTB domain containing 5 |
chr1_+_67123015 | 0.68 |
ENSMUST00000027144.7
|
Cps1
|
carbamoyl-phosphate synthetase 1 |
chr12_-_31559969 | 0.68 |
ENSMUST00000001253.7
|
Slc26a4
|
solute carrier family 26, member 4 |
chr14_-_66009204 | 0.68 |
ENSMUST00000059970.7
|
Gulo
|
gulonolactone (L-) oxidase |
chr3_+_5218589 | 0.67 |
ENSMUST00000177488.1
|
Zfhx4
|
zinc finger homeodomain 4 |
chr8_-_25038875 | 0.67 |
ENSMUST00000084031.4
|
Htra4
|
HtrA serine peptidase 4 |
chr11_-_106920359 | 0.67 |
ENSMUST00000167787.1
ENSMUST00000092517.2 |
Smurf2
|
SMAD specific E3 ubiquitin protein ligase 2 |
chrM_-_14060 | 0.67 |
ENSMUST00000082419.1
|
mt-Nd6
|
mitochondrially encoded NADH dehydrogenase 6 |
chr12_-_80968075 | 0.66 |
ENSMUST00000095572.4
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr4_+_102570065 | 0.66 |
ENSMUST00000097950.2
|
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr6_-_138073196 | 0.66 |
ENSMUST00000050132.3
|
Slc15a5
|
solute carrier family 15, member 5 |
chr11_-_100397740 | 0.66 |
ENSMUST00000001592.8
ENSMUST00000107403.1 |
Jup
|
junction plakoglobin |
chr7_+_101317073 | 0.65 |
ENSMUST00000163799.2
ENSMUST00000164479.2 |
Stard10
|
START domain containing 10 |
chr18_-_66022580 | 0.65 |
ENSMUST00000143990.1
|
Lman1
|
lectin, mannose-binding, 1 |
chr6_+_124304646 | 0.65 |
ENSMUST00000112541.2
ENSMUST00000032234.2 |
Cd163
|
CD163 antigen |
chr19_+_26750939 | 0.65 |
ENSMUST00000175953.1
|
Smarca2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr6_-_52640303 | 0.64 |
ENSMUST00000031788.8
|
Hibadh
|
3-hydroxyisobutyrate dehydrogenase |
chr12_-_103738158 | 0.64 |
ENSMUST00000095450.4
|
Serpina1b
|
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
chr6_-_142322978 | 0.64 |
ENSMUST00000081380.3
|
Slco1a5
|
solute carrier organic anion transporter family, member 1a5 |
chr16_+_20097554 | 0.64 |
ENSMUST00000023509.3
|
Klhl24
|
kelch-like 24 |
chr1_-_153851189 | 0.63 |
ENSMUST00000059607.6
|
5830403L16Rik
|
RIKEN cDNA 5830403L16 gene |
chr9_-_44802951 | 0.63 |
ENSMUST00000044694.6
|
Ttc36
|
tetratricopeptide repeat domain 36 |
chr7_+_130692532 | 0.63 |
ENSMUST00000033141.6
|
Tacc2
|
transforming, acidic coiled-coil containing protein 2 |
chr3_-_146596588 | 0.63 |
ENSMUST00000029836.4
|
Dnase2b
|
deoxyribonuclease II beta |
chr2_-_176917518 | 0.62 |
ENSMUST00000108931.2
|
Gm14296
|
predicted gene 14296 |
chr10_+_62071014 | 0.61 |
ENSMUST00000053865.5
|
Gm5424
|
predicted gene 5424 |
chr6_+_53573364 | 0.61 |
ENSMUST00000047450.7
|
Creb5
|
cAMP responsive element binding protein 5 |
chr6_-_134897815 | 0.60 |
ENSMUST00000165392.1
ENSMUST00000046255.7 ENSMUST00000111932.1 ENSMUST00000116515.2 |
Gpr19
|
G protein-coupled receptor 19 |
chr19_-_46672883 | 0.60 |
ENSMUST00000026012.7
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr9_-_103230415 | 0.59 |
ENSMUST00000035158.9
|
Trf
|
transferrin |
chr16_+_43510267 | 0.59 |
ENSMUST00000114695.2
|
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr2_+_145785980 | 0.58 |
ENSMUST00000110005.1
ENSMUST00000094480.4 |
Rin2
|
Ras and Rab interactor 2 |
chr5_-_96164147 | 0.58 |
ENSMUST00000137207.1
|
Cnot6l
|
CCR4-NOT transcription complex, subunit 6-like |
chr2_-_64975762 | 0.58 |
ENSMUST00000156765.1
|
Grb14
|
growth factor receptor bound protein 14 |
chr15_-_50890396 | 0.58 |
ENSMUST00000185183.1
|
Trps1
|
trichorhinophalangeal syndrome I (human) |
chr19_-_43986552 | 0.58 |
ENSMUST00000026210.4
|
Cpn1
|
carboxypeptidase N, polypeptide 1 |
chr9_+_7272514 | 0.58 |
ENSMUST00000015394.8
|
Mmp13
|
matrix metallopeptidase 13 |
chr1_+_131970589 | 0.58 |
ENSMUST00000027695.6
|
Slc45a3
|
solute carrier family 45, member 3 |
chr14_+_48120841 | 0.57 |
ENSMUST00000073150.4
|
Peli2
|
pellino 2 |
chr7_-_25390098 | 0.57 |
ENSMUST00000054301.7
|
Lipe
|
lipase, hormone sensitive |
chr3_+_5218546 | 0.57 |
ENSMUST00000026284.6
|
Zfhx4
|
zinc finger homeodomain 4 |
chr8_+_45627709 | 0.57 |
ENSMUST00000134321.1
ENSMUST00000135336.1 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr19_+_5877794 | 0.56 |
ENSMUST00000145200.1
ENSMUST00000025732.7 ENSMUST00000125114.1 ENSMUST00000155697.1 |
Slc25a45
|
solute carrier family 25, member 45 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.0 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.9 | 5.7 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.8 | 4.1 | GO:0031438 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.6 | 2.4 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.6 | 2.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 2.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.5 | 1.6 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.5 | 3.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 2.2 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.4 | 1.3 | GO:0090649 | rRNA export from nucleus(GO:0006407) response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.4 | 1.2 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 2.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.4 | 3.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 2.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 1.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.3 | 1.9 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.3 | 1.6 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 0.9 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.3 | 1.7 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 4.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 0.8 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.3 | 1.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 1.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 4.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 0.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 8.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 2.1 | GO:0046449 | creatinine metabolic process(GO:0046449) |
0.2 | 1.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 1.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.6 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.2 | 0.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 0.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.7 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.2 | 0.7 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.2 | 0.5 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.2 | 0.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.2 | 0.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 2.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.7 | GO:1990401 | embryonic lung development(GO:1990401) |
0.2 | 0.5 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.2 | 1.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 1.5 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 0.5 | GO:0021759 | globus pallidus development(GO:0021759) |
0.2 | 1.3 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 | 0.5 | GO:2000850 | negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.6 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.6 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.6 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.4 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.1 | 0.4 | GO:0090425 | hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.1 | 0.6 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 3.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.1 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.1 | 0.4 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.1 | 1.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 1.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 1.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.6 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.1 | 0.7 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.1 | 0.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 1.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 1.3 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 1.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.7 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.3 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.1 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.4 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.1 | 0.7 | GO:0002159 | desmosome assembly(GO:0002159) response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.4 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 2.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 1.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.5 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 1.5 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.7 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.1 | 0.2 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.5 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.7 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.9 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.5 | GO:0045994 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.1 | 1.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.9 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.1 | 0.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 1.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 1.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 0.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.3 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.1 | 0.4 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.1 | 0.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.2 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.1 | 0.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.1 | 1.6 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.3 | GO:0002780 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
0.1 | 0.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.2 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.1 | 0.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.4 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 1.2 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.4 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.1 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) |
0.1 | 1.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.2 | GO:0097274 | urea homeostasis(GO:0097274) |
0.1 | 0.8 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 1.6 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 1.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 1.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 1.0 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.4 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.9 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.9 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 1.0 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 0.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.2 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.1 | 0.2 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.1 | 0.7 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 0.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.4 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.2 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.1 | 0.3 | GO:0006048 | glucosamine metabolic process(GO:0006041) UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.7 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.4 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.4 | GO:0009313 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.3 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.1 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.0 | 0.2 | GO:0050904 | diapedesis(GO:0050904) |
0.0 | 0.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.4 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 0.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.0 | 0.2 | GO:2001205 | negative regulation of bone development(GO:1903011) negative regulation of osteoclast development(GO:2001205) |
0.0 | 0.9 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.4 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.3 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.0 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.6 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 2.4 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 0.5 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 1.8 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 1.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.3 | GO:2000124 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 0.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 1.0 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 4.5 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.0 | 0.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.0 | 0.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.0 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 | 0.1 | GO:0042335 | cuticle development(GO:0042335) |
0.0 | 0.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.0 | 0.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.4 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.4 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.0 | 0.2 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.0 | 0.1 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.0 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.4 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.0 | 0.1 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.0 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.8 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.0 | 0.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.0 | 0.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.0 | 0.2 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.0 | 0.5 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.2 | GO:0072033 | renal vesicle formation(GO:0072033) ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.5 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.6 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.0 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0002587 | negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.4 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.4 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 1.3 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.0 | 2.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.0 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.6 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.2 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.1 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.0 | 0.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.3 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.0 | 0.0 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.0 | 0.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 1.1 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.0 | 0.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 1.0 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.2 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 0.1 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.0 | 2.1 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.0 | 0.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.1 | GO:0032308 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 1.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.4 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.4 | 4.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 1.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 3.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 0.8 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 0.8 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.2 | 2.1 | GO:0042567 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 2.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 3.4 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 5.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.5 | GO:0044307 | dendritic branch(GO:0044307) |
0.1 | 0.4 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.8 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 1.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 1.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.3 | GO:0098855 | HCN channel complex(GO:0098855) |
0.1 | 0.9 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.2 | GO:0044753 | amphisome(GO:0044753) |
0.1 | 0.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 2.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.5 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.2 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.0 | 0.2 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.6 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 1.7 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.2 | GO:0031673 | H zone(GO:0031673) |
0.0 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 4.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.2 | GO:0097227 | sperm annulus(GO:0097227) |
0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 9.3 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 1.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 3.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 2.1 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.3 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.5 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 6.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.7 | 2.1 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
0.7 | 4.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.6 | 3.1 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.6 | 4.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 5.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.5 | 3.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 2.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.5 | 1.4 | GO:0005118 | sevenless binding(GO:0005118) |
0.4 | 1.9 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.4 | 1.5 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.4 | 2.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.3 | 1.0 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.3 | 2.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 2.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.3 | 0.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.3 | 1.9 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 0.8 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 1.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 1.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.2 | 0.7 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.2 | 1.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.7 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.2 | 0.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 1.0 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.2 | 1.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.1 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.2 | 2.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.6 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.2 | 0.5 | GO:0019807 | aspartoacylase activity(GO:0019807) |
0.1 | 0.4 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 1.0 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.6 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 1.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.5 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.1 | 1.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 1.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.4 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.1 | 1.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 3.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 1.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 1.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 1.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 1.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 1.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 4.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.1 | GO:0071820 | N-box binding(GO:0071820) |
0.1 | 0.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 1.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.2 | GO:0005009 | insulin-activated receptor activity(GO:0005009) |
0.1 | 0.4 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.1 | 1.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.6 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 1.7 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 1.0 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 1.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 2.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.8 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.4 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 1.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 1.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.5 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 0.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 1.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 1.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 1.6 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 6.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.5 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) |
0.0 | 0.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.0 | 0.3 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 1.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.8 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 1.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0090556 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.0 | 0.8 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 0.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.3 | GO:0019841 | retinal binding(GO:0016918) retinol binding(GO:0019841) |
0.0 | 1.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.5 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 1.2 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 1.4 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 2.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.7 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 2.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 0.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.2 | GO:1990381 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) ubiquitin-specific protease binding(GO:1990381) |
0.0 | 1.1 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.4 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 4.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 4.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 5.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 2.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 1.6 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.8 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.4 | PID LKB1 PATHWAY | LKB1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 6.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 2.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 5.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 3.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 1.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 2.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 7.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 3.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 3.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 2.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 2.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 2.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 3.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 2.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 0.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 1.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 1.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 1.1 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 1.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 2.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 1.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 3.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 1.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |